Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 8, 2002

View Archived Issues

Ortho-McNeil submits sNDA for Levaquin for nosocomial pneumonia

IND submitted for AGI-1096 in prevention of organ transplant rejection

Abgenix initiates phase II trial of ABX-EGF in prostate cancer

IND approval for NicOx's HCT-1026 for urinary incontinence

Antitrust clearance obtained for MedImmune's acquisition of Aviron

ISTA files initial section of Vitrase NDA

Antisoma and Abbott revise pemtumomab licensing agreement

CancerVax files IND application to conduct pivotal trials of Canvaxin in advanced colon cancer

Nucleotide inhibitors of HBV replication under development at Origenix

Early clinical data indicate safety and efficacy of ISS-1018 coadministered with HBsAg

In vitro profile of PNU-177553, a new oxazolidinone, described at ICAAC meeting

15-Methylketolide derivatives of erythromycin A designed by R.W. Johnson and Kosan

GSK will market Natrecor in Europe under new agreement with Scios

Lead A2A antagonist selected by Vernalis for further development as potential PD therapy

LY-570310, a new oral hepatitis C protease inhibitor, designated a development candidate

Bacterial FabI inhibitors as novel antibiotics; GSK discusses findings at ICAAC

Phase IIa results of ABX-IL-8 in rheumatoid arthritis do not warrant progression to phase IIb trials

Contraceptive gel enters clinical trials

NB-1011 enters phase I/II trial in colon cancer

FDA approves IND for Albuleukin to enter clinical trials in treatment of cancer

Versicor initiates phase III trial for anidulafungin in invasive aspergillosis

Inhibitors of sCD23 formation and TNF processing patented by GSK

Oxadiazole MMP inhibitors reported useful for renal diseases in Shionogi patent

GSK-3beta inhibitors and their use described in recent patent

Dual 5-HT1A autoreceptor antagonists and 5-HT uptake inhibitors designed by AHP

New somatostatin receptor agonists selective for sst2 subtype and potential uses thereof

MMP-2 inhibitors identified at Shionogi as anticancer agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...